NCT02050295

Brief Summary

Injecting local anesthetic to anesthetize a nerve or group of nerves (a 'nerve block') is an effective way to eliminate pain during and after surgery. There are instances when it would be beneficial to the patient for the nerve block to be resolved quickly rather than waiting for it to naturally wear off. For example, a sciatic nerve block that freezes the lower leg and foot typically takes over 18 hours to resolve on its own, and both the surgeon and patient prefer to have motor function before discharge. The investigators wish to perform a randomized, controlled trial to determine if infusion of a solution such as saline to 'wash out' the nerve block after surgery can allow the patient to be pain-free while still being able to move their leg and foot.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 30, 2014

Completed
2 days until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

March 25, 2020

Status Verified

March 1, 2020

Enrollment Period

3.9 years

First QC Date

January 27, 2014

Last Update Submit

March 23, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Motor function

    Motor function (dorsiflexion and plantar flexion) in the absence of pain will be assessed in the period 72 hours following surgery or discharge from hospital, whichever comes first.

    Within 72 hours post-surgery

Secondary Outcomes (4)

  • Sensory function

    Within 72 hours post-surgery

  • Pain

    Within 72 hours post-surgery

  • Patient satisfaction

    Within 72 hours post-surgery

  • Time to first oral analgesic

    Within 72 hours post-surgery

Study Arms (2)

Nerve block washout

EXPERIMENTAL

Patients will receive a washout infusion of saline through their perineural catheter to reverse their motor block while maintaining the sensory block.

Procedure: Nerve block washoutDrug: Saline

Sham washout

SHAM COMPARATOR

Patients will receive an infusion of saline run just enough to maintain catheter patency.

Procedure: Sham washoutDrug: Saline

Interventions

Saline will be infused through the perineural catheter to reverse motor block.

Nerve block washout
Sham washoutPROCEDURE

Infusion of saline to maintain catheter patency.

Sham washout
SalineDRUG
Also known as: Normal saline, Saline 0.9%
Nerve block washoutSham washout

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provide informed written consent
  • Adult (≥ 18 years old) patients
  • Scheduled for lower extremity surgery wholly or partially under popliteal sciatic nerve block

You may not qualify if:

  • Failure to provide informed consent
  • Infection at the needle insertion site
  • Known coagulopathy
  • Known allergy to local anesthetics
  • Presence of sensory or motor impairment in the distribution of the sciatic nerve prior to nerve blockade
  • Inability to perform valid sensory or motor examination of the function of the sciatic nerve prior to nerve blockade due to impaired access to the limb, language barrier, or inability of the subject to co-operate with such examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta Hospital

Edmonton, Alberta, T6G 2G3, Canada

Location

Related Publications (6)

  • Urmey WF, Talts KH, Sharrock NE. One hundred percent incidence of hemidiaphragmatic paresis associated with interscalene brachial plexus anesthesia as diagnosed by ultrasonography. Anesth Analg. 1991 Apr;72(4):498-503. doi: 10.1213/00000539-199104000-00014.

    PMID: 2006740BACKGROUND
  • Katircioglu K, Ozkalkanli MY, Kalfaoglu H, Sannav S, Ozgurbuz U, Savaci S. Reversal of prilocaine epidural anesthesia using epidural saline or ringer's lactate washout. Reg Anesth Pain Med. 2007 Sep-Oct;32(5):389-92. doi: 10.1016/j.rapm.2007.06.004.

    PMID: 17961836BACKGROUND
  • Park EY, Kil HK, Park WS, Lee NH, Hong JY. Effect of epidural saline washout on regression of sensory and motor block after epidural anaesthesia with 2% lidocaine and fentanyl in elderly patients. Anaesthesia. 2009 Mar;64(3):273-6. doi: 10.1111/j.1365-2044.2008.05746.x.

    PMID: 19302639BACKGROUND
  • Sitzman BT, DiFazio CA, Playfair PA, Stevens RA, Hanes CF, Herman TB, Yates HK, Leisure GS. Reversal of lidocaine with epinephrine epidural anesthesia using epidural saline washout. Reg Anesth Pain Med. 2001 May-Jun;26(3):246-51. doi: 10.1053/rapm.2001.22587.

    PMID: 11359224BACKGROUND
  • Taboada Muniz M, aLvarez J, Cortes J, Rodrguez J, Atanassoff PG. Lateral approach to the sciatic nerve block in the popliteal fossa: correlation between evoked motor response and sensory block. Reg Anesth Pain Med. 2003 Sep-Oct;28(5):450-5. doi: 10.1016/j.rapm.2003.08.007.

    PMID: 14556137BACKGROUND
  • Tsui BCH, Malherbe S, Koller J, Aronyk K. Reversal of an unintentional spinal anesthetic by cerebrospinal lavage. Anesth Analg. 2004 Feb;98(2):434-436. doi: 10.1213/01.ANE.0000095152.81728.DC.

    PMID: 14742383BACKGROUND

MeSH Terms

Interventions

Sodium ChlorideSaline Solution

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2014

First Posted

January 30, 2014

Study Start

February 1, 2014

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

March 25, 2020

Record last verified: 2020-03

Locations